Stock listing

SET:APCO Asian Phytoceuticals Public Co., Ltd. (เอเชียน ไฟย์โตซูติคอลส์) หุ้น

Home listing (SET) of Asian Phytoceuticals Public Co., Ltd.

Follow Asian Phytoceuticals Public Co., Ltd. into a list and get an email when it puts out news.

Share price · SET:APCO

2.56 THB +0.02 (+0.8%)

Close on Nov 20, 2026

Past 3 months -0.8% · daily closes, Jul 6, 2026 – Nov 20, 2026, adjusted for splits
Day range
2.44 – 2.56 THBNov 20, 2026
Volume
90,001 sharesNov 20, 2026
Market cap
1.54B THBAt the close on Nov 20, 2026 · price × 600.0M shares outstanding
Traded on an average day
180,553 THBMedian day 43,616 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Asian Phytoceuticals Public Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SET:APCO · THB, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.56+0.02+0.8%2.522.562.4490,001
2.54+0.04+1.6%2.502.542.40247,200
2.500.000.0%2.462.502.44100,400
2.50+0.02+0.8%2.482.502.4292,000
2.48-0.02-0.8%2.402.482.36430,500
2.500.000.0%2.502.502.4812,710
2.500.000.0%2.502.502.4644,400
2.50-0.02-0.8%2.502.502.483,509
2.52+0.02+0.8%2.502.522.5056,101
2.50+0.02+0.8%2.482.502.4659,083
2.48-0.02-0.8%2.482.482.30176,500
2.500.000.0%2.482.502.4637,500
2.500.000.0%2.502.502.46134,600
2.50-0.02-0.8%2.462.662.46219,410
2.520.000.0%2.502.522.4870,919
2.520.000.0%2.502.522.44200,639
2.520.000.0%2.482.522.4830,300
2.52+0.04+1.6%2.482.522.4676,200
2.48-0.02-0.8%2.462.502.4628,500
2.500.000.0%2.502.522.4898,918
2.50-0.02-0.8%2.502.522.48253,607
2.520.000.0%2.482.522.48126,500
2.520.000.0%2.482.522.4865,702
2.520.000.0%2.502.522.4899,000
2.520.000.0%2.482.522.4830,100
2.520.000.0%2.502.522.4830,000
2.520.000.0%2.482.522.46156,820
2.520.000.0%2.522.522.5075,087
2.52-0.02-0.8%2.502.542.5010,810
2.540.000.0%2.522.542.5218,043
2.540.000.0%2.502.542.5011,200
2.54+0.02+0.8%2.482.542.4831,900
2.520.000.0%2.522.522.4855,730
2.52-0.02-0.8%2.542.562.5014,502
2.540.000.0%2.522.542.5016,705
2.540.000.0%2.542.542.528,805
2.540.000.0%2.522.562.5039,600
2.540.000.0%2.522.562.5236,304
2.54+0.02+0.8%2.522.542.5038,217
2.52-0.02-0.8%2.522.542.50100,931
2.54+0.02+0.8%2.542.582.5021,242
2.52-0.06-2.3%2.582.582.5053,142
2.58+0.04+1.6%2.522.582.5210,401
2.54-0.04-1.6%2.542.562.5243,616
2.580.000.0%2.582.582.562,918
2.580.000.0%2.542.582.548,408
2.58+0.04+1.6%2.502.582.5043,601
2.540.000.0%2.522.542.505,605
2.54+0.02+0.8%2.522.542.5021,785
2.520.000.0%2.522.522.4897,114
2.52-0.04-1.6%2.542.582.5213,100
2.56-0.02-0.8%2.562.582.5254,119
2.580.000.0%2.562.582.563,602
Ticker
SET:APCO
Asset type
Stock
Sector
Consumer goods
Industry
Household & personal care
Exchange
SET
Currency
THB

What changed lately

Latest news

All Asian Phytoceuticals Public Co., Ltd. news

Asian Phytoceuticals Public Co., Ltd. on 6ix

Sector
Consumer goods
Industry
Household & personal care
News releases
2 in all · newest Apr 18, 2022 · oldest 2022
Decks
27 decks · latest Aug 27, 2026

Where Asian Phytoceuticals Public Co., Ltd. is listed

ListingExchangeCountryCurrency
SET:APCO เอเชียน ไฟย์โตซูติคอลส์ · Home listing · This pageSETThailandTHB
SET:APCO.R เอเชียน ไฟย์โตซูติคอลส์SETThailandTHB
SET:APCO.F เอเชียน ไฟย์โตซูติคอลส์SETThailandTHB

Valuation

P/E 26.6× against a median of 11.9×: the highest of 8 Household & personal care companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
1.20B THB
P/E
26.6×
EV/sales
6.1×
EV/EBITDA
16.2×
Price/book
2.9×
Gross margin
84.5%
Operating margin
27.7%
Net margin
29.4%
Debt to equity
0.0×
Beta
No index for this market yet

Household & personal care: the 10 companies nearest in size, of 134 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Asian Phytoceuticals Public Co., Ltd. · SET:APCOUS$45.23MUS$35.29M26.6×6.1×16.2×2.9×29.4%0.0×n/a
Ming Fai International Holdings Limited · HKEX:3828US$60.89MUS$16.13M4.7×0.1×0.7×0.3×4.5%0.0×n/a
BBIA Co., Ltd. · KRX:451250US$57.00MUS$39.61M10.9×0.7×5.5×1.7×9.1%0.0×n/a
Aromatica Co., Ltd. · KRX:0015N0US$51.76MUS$37.09M11.9×0.8×6.3×1.5×10.0%0.0×n/a
China Ludao Technology Co. Ltd. · HKEX:2023US$48.94MUS$173.3M5.8×1.0×12.5×0.5×5.0%1.5×n/a
Meiwu Technology Company Limited · NASDAQ:WNWUS$43.31MUS$25.47Mn/a3.6×n/a0.9×−262.5%0.0×0.95
Revolution Beauty Group plc · LSE:REVBUS$43.23MUS$77.77Mn/a0.6×n/an/a−30.2%n/an/a
Kuangli Bio-Tech Holdings Co., Ltd. · TWSE:6431US$42.10MUS$46.64Mn/a4.2×n/a2.8×−52.4%1.0×n/a
Dr. Miele Cosmed Group S.A. · GPW:DMGUS$37.82MUS$52.44M12.4×0.4×6.3×0.6×2.5%0.2×n/a
China Golden Classic Group Ltd. · HKEX:8281US$35.08MUS$25.53M20.2×0.6×6.0×0.9×4.2%0.0×n/a
Monalisa Co., Ltd · KRX:012690US$34.36MUS$22.72M21.7×0.2×4.5×0.5×1.6%0.0×n/a
Median of the othersUS$43.27MUS$38.35M11.9×0.7×6.0×0.9×3.4%0.0×0.95

Team and board

Officers

OfficerRole
Pichaet WiriyachitraDirector / Chairman of Executive Committee / Chief Executive Officer
Assoc.Prof.Arunee WiriyachitraDirector / Executive Committee
Dr.Jingjai HanchanlashDirector / Executive Committee

Board

DirectorRole
Maleeratna PlumchitchomeIndependent Director / Chairperson of the Board / Chairperson of the Audit Committee
Assoc.Prof.Arunee WiriyachitraDirector / Executive Committee
Assoc.Prof.Dr.Varakorn SamakosesIndependent Director / Audit Committee
Dr.Jingjai HanchanlashDirector / Executive Committee
Montien SirisoonthornlakDirector
Pichaet WiriyachitraDirector / Chairman of Executive Committee / Chief Executive Officer
Prof.Dr.Praipol KoomsupIndependent Director / Audit Committee

Events

QuarterResults
Q1 2025May 9, 2025
Q4 2024Mar 4, 2025
Q3 2024Nov 13, 2024
Q2 2024Aug 9, 2024
Q1 2024May 14, 2024
Q4 2023Feb 28, 2024
Q3 2023Nov 10, 2023
Q2 2023Aug 9, 2023
Q1 2023May 12, 2023
Q4 2022Feb 22, 2023
All 18 quarters
QuarterResults
Q3 2022Nov 9, 2022
Q2 2022Aug 9, 2022
Q1 2022May 13, 2022
Q4 2021Feb 28, 2022
Q3 2021Dec 1, 2021
Quarter to Jun 30, 2021Aug 10, 2021
Quarter to Mar 31, 2021May 13, 2021
Quarter to Dec 31, 2020Feb 25, 2021

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings64 slidesAug 27, 2026
Q1 2026 Earnings PresentationEarnings46 slidesMay 28, 2026
Q4 2025 Earnings PresentationEarnings5 slidesMar 12, 2026
Corporate Update (November 2025)Corporate update45 slidesNov 27, 2025
Q2 2025 Earnings PresentationEarnings31 slidesAug 27, 2025
Q1 2025 Earnings PresentationEarnings30 slidesMay 27, 2025
Q4 2024 Earnings PresentationEarnings55 slidesMar 7, 2025
Q3 2024 Earnings PresentationEarnings23 slidesNov 28, 2024
Q2 2024 Earnings PresentationEarnings36 slidesSep 2, 2024
Q1 2024 Earnings PresentationEarnings36 slidesMay 31, 2024
All 27 decks
DeckKindSlidesDate
Shareholder Meeting (April 2024)Shareholder meeting24 slidesApr 22, 2024
Q2 2023 Earnings PresentationEarnings32 slidesSep 13, 2023
Q1 2023 Earnings PresentationEarnings46 slidesJun 9, 2023
Shareholder Meeting (April 2023)Shareholder meeting34 slidesApr 26, 2023
FY2022 Earnings PresentationEarnings50 slidesMar 3, 2023
Q3 2022 Earnings PresentationEarnings23 slidesDec 2, 2022
Q1 2022 Earnings PresentationEarnings22 slidesMay 30, 2022
Q3 2021 Earnings PresentationEarnings34 slidesDec 7, 2021
Q2 2021 Earnings PresentationEarnings40 slidesSep 10, 2021
Q1 2021 Earnings PresentationEarnings63 slidesJun 14, 2021
Q3 2020 Earnings PresentationEarnings61 slidesDec 2, 2020
Q3 2019 Earnings PresentationEarnings91 slidesDec 4, 2019
Q1 2019 Earnings PresentationEarnings29 slidesMay 24, 2019
FY2018 Earnings PresentationEarnings36 slidesMar 25, 2019
Q3 2018 Earnings PresentationEarnings22 slidesNov 29, 2018
Q2 2018 Earnings PresentationEarnings52 slidesSep 4, 2018
Q1 2018 Earnings PresentationEarnings41 slidesMay 24, 2018

Open Decks

Financials

Annual, in THB

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue200.2M210.8M292.8M250.4M223.4M247.7M247.7M369.8M415.7M421.4M
Cost of revenue31.1M41.0M57.2M47.9M46.3M52.9M51.8M64.9M67.5M59.6M
Gross profit169.0M169.9M235.5M202.4M177.1M194.9M195.8M304.9M348.3M361.8M
Research and development4.73M5.05M7.21M6.10M5.82M6.44M162.5K1.63M16.6M9.26M
Selling, general and administrative62.0M67.2M66.3M68.4M70.4M75.9M78.2M80.4M84.7M85.6M
Operating income53.6M53.1M116.9M88.0M73.8M75.5M64.9M110.1M122.8M164.3M
Depreciation and amortization19.6M20.7M22.2M23.2M27.0M31.2M13.6M13.8M14.5M17.0M
EBITDA73.2M73.8M139.0M111.3M100.8M106.8M78.5M123.9M137.2M181.3M
Interest expense1.61M1.59M661.3K566.2K864.3K476.5K0000
Income before tax69.7M68.0M133.2M100.5M85.5M87.1M72.4M117.7M131.6M164.3M
Income tax13.1M12.2M24.4M19.3M16.8M17.1M14.5M22.9M23.4M32.8M
Net income55.4M54.7M107.5M80.9M68.7M70.0M57.9M94.7M108.2M131.4M
Earnings per share, basic0.090.090.180.130.110.120.100.160.180.24

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents102.5M62.4M125.6M82.1M98.6M100.2M160.3M182.4M244.3M222.5M
Short-term investments257.2M289.3M125.6M97.0M68.3M71.8M319.5M313.4M270.5M315.5M
Receivables3.77M5.49M4.22M4.21M3.29M5.29M1.44M5.25M4.55M4.97M
Inventory69.1M57.0M44.3M52.5M58.6M60.3M61.0M65.5M51.1M48.2M
Current assets438.0M415.5M300.8M237.5M231.1M240.7M544.5M569.4M573.6M595.6M
Property, plant and equipment64.0M91.2M113.4M71.4M83.6M93.8M106.7M
Total assets631.1M636.0M704.7M680.1M680.5M696.8M629.8M665.7M678.8M711.2M
Accounts payable1.01M765.7K1.20M635.8K1.99M630.8K690.2K1.74M1.55M1.75M
Current liabilities40.4M38.6M46.2M45.1M47.8M48.9M31.2M36.9M37.8M50.3M
Total debt13.7M24.1M35.7M13.8M34.2M50.0M
Total liabilities70.9M76.3M92.3M69.6M85.5M101.3M50.6M51.6M50.5M62.1M
Shareholders' equity557.0M556.8M609.7M608.0M595.0M595.5M579.2M614.2M628.3M649.1M
Shares outstanding600.0M600.0M599.8M600.0M600.0M600.0M600.0M600.0M600.0M554.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations60.1M37.7M124.1M100.2M84.4M86.7M71.7M87.2M102.2M124.7M
Capital spending-799.0K-2.31M-4.10M-322.2K-1.17M-4.18M-1.21M-3.43M-1.78M-1.34M
Free cash flow59.3M35.4M120.0M99.9M83.2M82.6M70.5M83.8M100.5M123.4M
Cash from investing50.5M23.3M12.8M-28.8M4.95M-70.7M-918.0K-41.2M48.6M-64.7M
Cash from financing-70.4M-124.2M-109.7M-87.8M-91.0M-76.2M-92.9M-108.0M-129.0M-51.3M
Dividends paid-55.2M-107.9M-92.9M-74.0M-72.0M-57.0M-92.9M-108.0M-129.0M-95.3M
Share buybacks44.0M
Change in cash40.1M-63.3M43.5M-16.4M-1.61M-60.1M-22.1M-61.9M21.8M8.69M

Open Financials

Cap table

Built by 6ix from Asian Phytoceuticals Public Co., Ltd.’s releases

Common shares
600,000,000
Fully diluted
600,000,000

Fully diluted

LineShares
Common shares600,000,000

Share count over time

CountShares
Nov 22, 2026600,000,000

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Assoc.Prof.Arunee WiriyachitraDirector / Executive Committee · Since at least Nov 4, 2026
Assoc.Prof.Dr.Varakorn SamakosesIndependent Director / Audit Committee · Since at least Nov 4, 2026
Dr.Jingjai HanchanlashDirector / Executive Committee · Since at least Nov 4, 2026
Maleeratna PlumchitchomeIndependent Director / Chairperson of the Board / Chairperson of the Audit Committee · Since at least Nov 4, 2026
Montien SirisoonthornlakDirector · Since at least Nov 4, 2026
Pichaet WiriyachitraDirector / Chairman of Executive Committee / Chief Executive Officer · Since at least Nov 4, 2026
Prof.Dr.Praipol KoomsupIndependent Director / Audit Committee · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Asian Phytoceuticals Public Co., Ltd.